The long-term goal of Project Transform is to integrate the patient experience into lung cancer treatment, research, and policy.
LUNGevity launched Project Transform in partnership with Johns Hopkins School of Public Health to focus on developing and applying novel methods (eg, discrete-choice experiments) to scientifically quantify patient preferences for the benefits and risks of treatments for lung cancer. The results obtained from this initiative will be used to inform regulators, industry, and clinicians of the preferences of people living with lung cancer.
The objectives of Project Transform are:
- To develop novel stated-preference methods to measure treatment preferences of patients
- To document NSCLC patients’ perspectives as to what constitutes meaningful benefits, what acceptable benefit-risk tradeoffs are, and patient preference heterogeneity (eg, differences in treatment preferences based on histology and age)
- To disseminate the results of the preference study to lung cancer patients and other stakeholders in lung cancer research, treatment, and policy